Nation's largest puzzle maker will donate percentage of sales from Puzzles to Remember product line to support Alzheimer's research
WELLESLEY, Mass., July 27, 2017 – Cure Alzheimer's Fund announced today that it has partnered with Kansas City-based puzzle manufacturer Springbok Puzzles. Springbok has created a line of jigsaw puzzles – Puzzles to Remember – specifically designed for patients with Alzheimer's disease. Springbok will donate $3 of every puzzle sold on
(CHICAGO, IL) – OCTOBER 7, 2016 – Rotary and Cure Alzheimer’s Fund today announced an agreement to co-fund a new, groundbreaking research project to search for female-specific genetic and other factors contributing to women’s risk for Alzheimer’s disease. In total, the two organizations will provide a grant of $375,000 for this critical research.
(New York City, NY) – August 8, 2016 –CaringKind, New York City’s leading expert in Alzheimer's and dementia care for the past three decades, has formed an alliance with Cure Alzheimer’s Fund, a non-profit dedicated to funding research to prevent, slow, or reverse the disease.
Organization achieves 4-star rating for 5th consecutive time
(Wellesley, MA) – June 2016 – Cure Alzheimer’s Fund is announcing that Charity Navigator has assigned the organization a score of 100 percent regarding its overall financial health. The nation's largest and most-utilized evaluator of charities, Charity Navigator assigned this score by evaluating two areas of the Fund’s performance – financial health and accountability/transparency – through the IRS Form 990.
Cure Alzheimer’s Fund will partner with Maria Shriver and Equinox Sports Clubs for the MOVE FOR MINDS Experience on May 21st. 100 percent of the donations generated from this experience will go to partner organizations of The Women's Alzheimer's Challenge, of which Cure Alzheimer’s Fund is a part.
A stem cell model of familial Alzheimer’s disease (FAD) was successfully generated in a recent study, allowing researchers to identify 14 genes potentially implicated in the disease. One gene in particular demonstrates the important role inflammation may play in the brain of Alzheimer’s patients. The study was completed by scientists at The New York Stem Cell Foundation (NYSCF) Research Institute in collaboration with scientists at the Icahn School of Medicine at Mount Sinai (ISMMS) and funded in part by the Cure Alzheimer’s Fund (CAF).